Literature DB >> 18193028

A mouse model of intracerebral hemorrhage using autologous blood infusion.

Michal A Rynkowski1, Grace H Kim, Ricardo J Komotar, Marc L Otten, Andrew F Ducruet, Brad E Zacharia, Christopher P Kellner, David K Hahn, Maxwell B Merkow, Matthew C Garrett, Robert M Starke, Byung-Moon Cho, Sergei A Sosunov, E Sander Connolly.   

Abstract

The development of controllable and reproducible animal models of intracerebral hemorrhage (ICH) is essential for the systematic study of the pathophysiology and treatment of hemorrhagic stroke. In recent years, we have used a modified version of a murine ICH model to inject blood into mouse basal ganglia. According to our protocol, autologous blood is stereotactically infused in two stages into the right striatum to mimic the natural events of hemorrhagic stroke. Following ICH induction, animals demonstrate reproducible hematomas, brain edema formation and marked neurological deficits. Our technique has proven to be a reliable and reproducible means of creating ICH in mice in a number of acute and chronic studies. We believe that our model will serve as an ideal paradigm for investigating the complex pathophysiology of hemorrhagic stroke. The protocol for establishing this model takes about 2 h.

Entities:  

Mesh:

Year:  2008        PMID: 18193028     DOI: 10.1038/nprot.2007.513

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  70 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

2.  Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation.

Authors:  Yijun Cheng; Yongxu Wei; Wenlei Yang; Yaying Song; Hanbing Shang; Yu Cai; Zhebao Wu; Weiguo Zhao
Journal:  Metab Brain Dis       Date:  2017-04-11       Impact factor: 3.584

3.  Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.

Authors:  Qingyi Ma; Anatol Manaenko; Nikan H Khatibi; Wanqiu Chen; John H Zhang; Jiping Tang
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

Review 4.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

Review 5.  History of preclinical models of intracerebral hemorrhage.

Authors:  Qingyi Ma; Nikan H Khatibi; Hank Chen; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

Review 6.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

7.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

8.  Transplantation of neural stem cells that overexpress SOD1 enhances amelioration of intracerebral hemorrhage in mice.

Authors:  Takuma Wakai; Hiroyuki Sakata; Purnima Narasimhan; Hideyuki Yoshioka; Hiroyuki Kinouchi; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

Review 9.  Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery.

Authors:  Balachandar Kathirvelu; S Thomas Carmichael
Journal:  Metab Brain Dis       Date:  2014-05-10       Impact factor: 3.584

Review 10.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.